CL2009001564A1 - Feline leukemia virus (felv) vaccine comprising an adenovirus containing a felv gene; recombinant adenovirus comprising a felv adenovirus DNA. - Google Patents

Feline leukemia virus (felv) vaccine comprising an adenovirus containing a felv gene; recombinant adenovirus comprising a felv adenovirus DNA.

Info

Publication number
CL2009001564A1
CL2009001564A1 CL2009001564A CL2009001564A CL2009001564A1 CL 2009001564 A1 CL2009001564 A1 CL 2009001564A1 CL 2009001564 A CL2009001564 A CL 2009001564A CL 2009001564 A CL2009001564 A CL 2009001564A CL 2009001564 A1 CL2009001564 A1 CL 2009001564A1
Authority
CL
Chile
Prior art keywords
felv
adenovirus
vaccine
gene
leukemia virus
Prior art date
Application number
CL2009001564A
Other languages
Spanish (es)
Inventor
Teshome Mebatsion
Perry Richard Linz
Jessica A Moore
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of CL2009001564A1 publication Critical patent/CL2009001564A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Vacuna contra el virus de la leucemia felina (felv) que comprende un adenovirus que contiene un gen del felv; adenovirus recombinante que comprende un ADN del adenovirus del felv.Feline leukemia virus (felv) vaccine comprising an adenovirus containing a felv gene; recombinant adenovirus comprising a felv adenovirus DNA.

CL2009001564A 2008-07-11 2009-07-09 Feline leukemia virus (felv) vaccine comprising an adenovirus containing a felv gene; recombinant adenovirus comprising a felv adenovirus DNA. CL2009001564A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7991508P 2008-07-11 2008-07-11

Publications (1)

Publication Number Publication Date
CL2009001564A1 true CL2009001564A1 (en) 2010-09-24

Family

ID=41057524

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2009001564A CL2009001564A1 (en) 2008-07-11 2009-07-09 Feline leukemia virus (felv) vaccine comprising an adenovirus containing a felv gene; recombinant adenovirus comprising a felv adenovirus DNA.

Country Status (3)

Country Link
AR (1) AR072555A1 (en)
CL (1) CL2009001564A1 (en)
WO (1) WO2010004043A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2570156C (en) * 2004-06-04 2014-09-30 Merial Limited Needle-free administration of felv vaccines

Also Published As

Publication number Publication date
WO2010004043A1 (en) 2010-01-14
AR072555A1 (en) 2010-09-08

Similar Documents

Publication Publication Date Title
CY1124627T1 (en) TARGETED GENE MODIFICATION OF THE RAT
ES2481040T3 (en) Immunostimulatory oligonucleotides
CL2015003185A1 (en) Apparatus for electroobtention or electrorefining
JP2011527560A5 (en)
SG162726A1 (en) Gene vector comprising mi-rna
BRPI0817560A2 (en) Engineered zinc claw proteins (zinc finger proteins) that target 5-enolpiruvil shiquimato-3-phosphate synthase genes
JP2009091351A5 (en)
JP2009091350A5 (en)
AR079882A1 (en) TOLERANT PLANTS TO INHIBITING HERBICIDES OF HPPD
EA201400170A1 (en) COMPOSITIONS AND METHODS FOR INHIBITING TRANSTIRETIN EXPRESSION
TR201815882T4 (en) Tal effector mediated DNA modification.
BRPI0918463A2 (en) methods for making and using an endodontic instrument, and endodontic instrument.
CL2007002182S1 (en) Terminal.
MY173789A (en) North american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof
BRPI0811755A2 (en) SPECIFIC AMPLIFICATION OF TUMOR SPECIFIC DNA SEQUENCE.
TR201903876T4 (en) Connector part for an optical plug-in type connection.
CL2013001077A1 (en) Kit for detecting bovine leukemia virus (blv) comprising a first and second primer for pcr; method for detecting bovine leukemia virus comprising amplifying a gene fragment obtained from blv.
CL2012000452A1 (en) Infectious nucleic acid of porcine torque virus (pttv), comprising sequence encoding an infectious pttv with a genomic sequence of pttv 1a-va; nucleic acid, plasmid and host cell comprising it; non-virulent infectious pttv; vaccine.
GB2461659A (en) Structured compositions comprising a clay
CL2011002913A1 (en) Novel plasmid with accession number mtcc 5561; Recombinant modified vaccinia ankara virus (mva).
DK2179035T3 (en) MODIFIED BACTERIOPHAGIC INCLUDING AN ALFA / BETA-SASP (SMALL ACID-SOLUBLE SPORE PROTEIN) GENE
WO2009153660A3 (en) Gene expression signatures for lung cancers
CY1110024T1 (en) Polypeptides having antimicrobial activity and polynucleotides encoding them
MX2009005817A (en) Agents for controlling parasites on animals.
CL2009001564A1 (en) Feline leukemia virus (felv) vaccine comprising an adenovirus containing a felv gene; recombinant adenovirus comprising a felv adenovirus DNA.